MDT

87.18

+1.2%↑

VEEV

287.41

+1.6%↑

A

117.98

-0.91%↓

HQY

104.54

-0.3%↓

PHR.US

28.41

+0.11%↑

MDT

87.18

+1.2%↑

VEEV

287.41

+1.6%↑

A

117.98

-0.91%↓

HQY

104.54

-0.3%↓

PHR.US

28.41

+0.11%↑

MDT

87.18

+1.2%↑

VEEV

287.41

+1.6%↑

A

117.98

-0.91%↓

HQY

104.54

-0.3%↓

PHR.US

28.41

+0.11%↑

MDT

87.18

+1.2%↑

VEEV

287.41

+1.6%↑

A

117.98

-0.91%↓

HQY

104.54

-0.3%↓

PHR.US

28.41

+0.11%↑

MDT

87.18

+1.2%↑

VEEV

287.41

+1.6%↑

A

117.98

-0.91%↓

HQY

104.54

-0.3%↓

PHR.US

28.41

+0.11%↑

Search

Incyte Corp

Fechado

SetorSaúde

67.91 -0.54

Visão Geral

Variação de preço das ações

24h

Atual

Mín

67.49

Máximo

68.77

Indicadores-chave

By Trading Economics

Rendimento

-43M

158M

Vendas

-126M

1.1B

P/E

Médio do Setor

336.3

50.291

EPS

1.16

Margem de lucro

15.025

Funcionários

2,617

EBITDA

-80M

257M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+12.06% upside

Dividendos

By Dow Jones

Próximos Ganhos

29 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-3.1B

13B

Abertura anterior

68.45

Fecho anterior

67.91

Sentimento de Notícias

By Acuity

19%

81%

32 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Incyte Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

30 de jun. de 2025, 21:26 UTC

Grandes Movimentos do Mercado

AeroVironment Shares Slide on Stock, Notes Offerings

30 de jun. de 2025, 16:50 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Won't Withdraw Sabadell Offer

30 de jun. de 2025, 23:43 UTC

Conversa de Mercado

Gold Edges Higher, Underpinned by Fed-Rate Cut Hopes -- Market Talk

30 de jun. de 2025, 23:38 UTC

Conversa de Mercado

Nikkei May Fall as Yen Has Strengthened Amid Trade Uncertainty -- Market Talk

30 de jun. de 2025, 23:38 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

30 de jun. de 2025, 23:03 UTC

Ganhos

Boeing CFO Exit Is Latest Change in Chief Executive Kelly Ortberg's C-Suite -- Update

30 de jun. de 2025, 22:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Giant Eagle Closes Sale of Its GetGo Business to Alimentation Couche-Tard

30 de jun. de 2025, 22:50 UTC

Ganhos

Boeing Hires Former Lockheed Martin Executive to Succeed CFO Brian West -- Update

30 de jun. de 2025, 21:26 UTC

Ganhos

Berkshire Stock Ends Quarter on Sour Note. It's About Even With S&P 500 So Far in 2025. -- Barrons.com

30 de jun. de 2025, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

30 de jun. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

30 de jun. de 2025, 19:46 UTC

Conversa de Mercado

Nike's Buzz is Back Amid Lean into Women Sports -- Market Talk

30 de jun. de 2025, 19:16 UTC

Conversa de Mercado

Oil Futures Snap Winning Streak on OPEC+ Outlook -- Market Talk

30 de jun. de 2025, 19:10 UTC

Conversa de Mercado

U.S. Natural Gas Wipes Out Friday's Gains -- Market Talk

30 de jun. de 2025, 19:07 UTC

Conversa de Mercado

Dollar Ends Losing Quarter Facing Downward Pressure -- Market Talk

30 de jun. de 2025, 18:27 UTC

Conversa de Mercado

Gold Has Largest Half-Year Gain Since 2007 -- Market Talk

30 de jun. de 2025, 17:08 UTC

Aquisições, Fusões, Aquisições de Empresas

MicroStrategy Stock Jumps After Latest Bitcoin Purchase as Holdings Near 600,000 Tokens -- Barrons.com

30 de jun. de 2025, 17:00 UTC

Aquisições, Fusões, Aquisições de Empresas

HPE Stock Soars as Juniper Merger Gets Regulatory Approval. There's Just 1 Catch. -- Barrons.com

30 de jun. de 2025, 16:41 UTC

Conversa de Mercado

WTI Crude Undeperforms as U.S.-Canada Trade Talks to Resume -- Market Talk

30 de jun. de 2025, 16:32 UTC

Conversa de Mercado

United Parks' Potential Buyback Resumption Could Be Catalyst For Stock -- Market Talk

30 de jun. de 2025, 16:23 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA: Offer Remains in Effect in Accordance With Applicable Regulations

30 de jun. de 2025, 16:22 UTC

Aquisições, Fusões, Aquisições de Empresas

BBVA Decided Not to Withdraw Offer for Banco De Sabadell

30 de jun. de 2025, 16:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

30 de jun. de 2025, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

30 de jun. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

30 de jun. de 2025, 16:07 UTC

Ganhos

Umicore to Post 1H Results on Aug 1

30 de jun. de 2025, 15:59 UTC

Conversa de Mercado

Copper Conditions Set to Remain Tight But Risks Loom -- Market Talk

30 de jun. de 2025, 15:55 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Home Depot to Consolidate Pro Distribution with GMS Deal -- Market Talk

30 de jun. de 2025, 15:54 UTC

Conversa de Mercado

Gold Futures Recoup Some Losses Though Demand Looks Set to Weaken -- Market Talk

30 de jun. de 2025, 15:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Google Bets Big on Nuclear Fusion With MIT Spinoff Commonwealth -- Barrons.com

Comparação entre Pares

Variação de preço

Incyte Corp Previsão

Preço-alvo

By TipRanks

12.06% parte superior

Previsão para 12 meses

Média 76.31 USD  12.06%

Máximo 107 USD

Mínimo 52 USD

Com base em 17 analistas de Wall Street que oferecem metas de preço de 12 meses para Incyte Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

17 ratings

7

Comprar

9

Manter

1

Vender

Pontuação Técnica

By Trading Central

59.52 / 62.66Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

32 / 380 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Incyte Corp

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation